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Background: Increased length of stay (LOS) for patients is an important measure of the
burden of healthcare-associated infection (HAI).
Aim: To estimate the excess LOS attributable to HAI.
Methods: This was a one-year prospective incidence study of HAI observed in one teaching
hospital and one general hospital in NHS Scotland as part of the Evaluation of Cost of
Nosocomial Infection (ECONI) study. All adult inpatients with an overnight stay were
included. HAI was diagnosed using European Centres for Disease Prevention and Control
definitions. A multi-state model was used to account for the time-varying nature of HAI
and the competing risks of death and discharge.
Findings: The excess LOS attributable to HAI was 7.8 days (95% confidence interval (CI):
5.7e9.9). Median LOS for HAI patients was 30 days and for non-HAI patients was 3 days.
Using a simple comparison of duration of hospital stay for HAI cases and non-cases would
overestimate the excess LOS by 3.5 times (27 days compared with 7.8 days). The greatest
impact on LOS was due to pneumonia (16.3 days; 95% CI: 7.5e25.2), bloodstream infec-
tions (11.4 days; 5.8e17.0) and surgical site infection (SSI) (9.8 days; 4.5e15.0). It is
estimated that 58,000 bed-days are occupied due to HAI annually.
Conclusion: Areductionof10%inHAI incidencecouldmake5800bed-daysavailable.Thesecould
be used to treat 1706 elective patients in Scotland annually and help reduce the number of
patients awaiting planned treatment. This study has important implications for investment
decisions in infectionpreventionandcontrol interventions locally, nationally,and internationally.
ª 2021 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.aledonian University, Cowcaddens Road, Glasgow G4 0BA, UK. Tel.: þ44 (0)1413 313536.
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Healthcare-associated infection (HAI) results in poor out-
comes for patients in terms of morbidity and mortality as well as
increased length of stay (LOS) and cost [1,2]. Increased LOS is a
useful measure of the cost burden of HAI and is used to support
arguments to increase investments in hospital infection pre-
vention and control (IPC) [1,3]. To retain credibility with
decision-makers and allocate scarce resources appropriately, it
is important to report unbiased estimates of HAI burden [4].
Although LOS is relatively simple to measure and data are
readily available on admission and discharge dates, several
factors complicate these analyses. The study design, pop-
ulation under investigation, type of HAI, and approach to
statistical analysis can result in large variations on estimates of
excess LOS. The potential for bias, especially time-dependent
bias, is not always accounted for in studies estimating the
additional LOS due to HAI [5]. Time-dependent bias occurs
when a patient’s entire hospital stay, or even the entire period
after the patient develops HAI, is attributed as additional LOS
due to the HAI, and this may lead to inflated estimates in excess
LOS linked with HAI. Despite these issues being well docu-
mented there are still a wide range of analytical approaches
used to estimate the excess attributable LOS due to HAI that
fail to address this issue [6e11]. The common analytical
approaches compare LOS in HAI and non-HAI groups, matching
HAI and non-HAI patients using characteristics that may affect
LOS, with and without accounting for time of infection, survival
analyses, and multi-state modelling [5]. There is considerable
heterogeneity in both study designs and analytical approaches
that prevent the use of meta-analysis or the use of these data
to inform IPC priorities and interventions.
The primary objectives of this study were to report the LOS
for patients with, and without, HAI and to report the excess
LOS attributable to HAI in order to determine which types of
HAI have the greatest impact on LOS.Methods
Study design
The Evaluation of Cost of Nosocomial Infection (ECONI)
study was designed to capture whole-hospital incidence
including all HAI types over one calendar year within a large
teaching hospital and a large general hospital within NHS
Scotland. Data were collected from April 2018 to March 2019
within the large teaching hospital and from July 2018 until June
2019 in the general hospital [12]. The large teaching hospital
had 981 beds including 16 general and nine cardiothoracic
intensive care beds and 13 general, eight cardiothoracic, and
12 transplant and renal high-dependency beds, and the large
general hospital had 492 beds including five intensive care and
four high-dependency beds [13]. These incidence data have
been used to estimate the excess LOS as a result of a range of
types of HAI using a multi-state modelling approach [14]. The
study hospitals were selected to be representative of acute
adult healthcare within NHS Scotland [15]. They offer the
majority of clinical specialties in Scotland and HAI prevalence
was around the median within the most recent HAI prevalence
survey undertaken before the study [16]. Teaching and general
hospitals accounted for 91% of all admissions to acute care inScotland in 2015 while the study was being developed [15].
Further detail of the method is described elsewhere [12].
All adults aged 18 years admitted overnight to the study
hospital during the study period were included. HAI was diag-
nosed using the internationally accepted European Centre for
Disease Prevention and Control (ECDC) case definitions [17].
Data were collected on all infection types applicable to adults,
including bloodstream infection (BSI), urinary tract infection
(UTI), lower respiratory tract infection (LRI), pneumonia, gas-
trointestinal infection (GI), surgical site infection (SSI), skin/
soft tissue (SST), bone and joint (BJ), cardiovascular (CV), eye,
ear, nose, and throat (EENT), and systemic infections.
Data collection
According to a previously published protocol, research
nurses were trained on the case definitions and standardized
data collection process [12]. Inter-rater reliability and vali-
dation were completed which indicated the data were of high
quality. Suspected cases were identified by microbiology
reports, then clinical notes were reviewed to ascertain
whether the case met the ECDC case definitions. Cases which
met the criteria were recorded electronically using a bespoke
database designed for the study using REDCap software [18].
For all inpatients admitted to the study hospital, records
were linked to the Scottish Morbidity Record 01 (SMR01), which
covers all hospital admissions and discharges to acute hospi-
tals, sourced from hospital administrative systems across
Scotland [19]. SMR01 was used to collect information for every
admission on date of the admission and discharge, age on
admission, sex, Scottish Index of Multiple Deprivation (SIMD),
specialty, and comorbidities using the International Classi-
fication of Diseases, 10th Revision (ICD-10) [20,21]. SIMD is the
Scottish Government’s standard approach to identify areas of
multiple deprivation in Scotland, looking at the extent to which
an area is deprived across seven domains: income, employ-
ment, education, health, access to services, crime, and hous-
ing [20]. Charlson Comorbidity Index was derived from the ICD-
10 comorbidities recorded within the SMR data set in the two
years prior to admission [22].
The two study hospitals had 107,244 admissions during 2015
when the study was being planned [12]. The primary power
calculation was based upon estimating the risks of developing
HAI. A hospital HAI incidence of about 0.5e1% of admissions was
anticipated, yielding around 500e1000 incident HAI cases over
the period of one year [12]. Previously published modelling using
prevalence data from the last European point-prevalence survey
estimated the expected hospital incidence of HAI using the
Rhame and Sudderth equation to estimate incidence of HAI from
prevalence data [23]. This was supported by the Scottish inci-
dence of HAI within the Healthcare Associated Infection Annual
report and the incidence of HAI reported within intensive care
units [24]. Previous estimates of excess LOS suggested a range of
5e15 days with standard deviations around 8e15 days [14,25].
With 1000 incident HAI cases we anticipated estimating mean
excess LOS to within1 day with 95% confidence; with 500 cases
this would be 1.4 days.
Estimation of excess LOS
Continuous variables were summarized as medians, ordinal




Figure 2. Four-state model used to estimate the excess length of
stay due to healthcare-associated infection (HAI).
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each admission as independent; many patients had multiple
admissions during the study period. An admission comprised a
patient’s continuous inpatient stay, defined as ‘an unbroken
period of time that a patient spends as an inpatient’, and was
obtained through record linkage to SMR01 data [26,27]. This
continuous inpatient stay is made up of one or more discrete
episodes of care within different specialties and significant
facilities.
Data were collected on all inpatient admissions during the
study period. Admissions and patient numbers included within
this analysis are described in Figure 1. An admission-level
approach to analysis was adopted as it was assumed that the
patient’s condition and likelihood to stay longer in hospital are
not constant over time and that these can change from one
admission to the next. Patient-level analysis may be further
complicated by patients having both HAI admissions and non-HAI
admissions during the study period. The approach used treats
each admission as a new event, and the readmitted patients
may, for example, have a different diagnosis or be older.
Multi-state model
A multi-state modelling approach was used, taking
account of time-varying exposures and the competing risks
of death and discharge (Figure 2). The critical parameters
within the data set are date of admission, date of onset of
HAI, and date of discharge or death. Patients entered the
initial state on each admission to hospital unless the infec-
tion date was before or equal to the admission date, in which
case the patient was assigned directly to the HAI state. The
ECDC case definitions allow HAI to be diagnosed if the
patient has recently been discharged from hospital. PatientsExcluded from analysis













Figure 1. Patients included within the admission level multi-state mo
*A total of 422 patients were included in both the healthcare-associate
are treated as independent).
**The ECONI study reported 1083 HAIs [30]. Thirty-three cases could
patients did not have valid Community Heath Index number (non-Scot
transcription error), and 15 patients (with 16 infections) did not have
(may still be in hospital).
***The 877 admissions included in analysis contained 1036 HAIs. If an
occurred at the time of the first infection and the patient remained iexited by entering one of two absorbing states of death or
discharged alive, with or without passing through the inter-
mediate HAI state. If an admission contained more than one
HAI, the state-change to HAI occurred at the time of the first
infection and the patient remained in the HAI state until
death/discharge/censored. Since transition from admission
to HAI could happen at any time, HAI was treated as a time-
varying exposure.
The probabilities of transitions between states, that is from
admission to discharge or death, or from admission to HAI and
then to discharge or death during the admission, were esti-
mated using the AaleneJohansen estimator [28]. The mean
excess LOS was then estimated by calculating the average
difference in LOS between patients with and without HAI at
each time, weighted by the observed distribution of time to
HAI. A total of 50 bootstrap samples were generated and the
distributional spread of the excess LOS assessed. Normality wasAdult inpatients
63,902 admissions
48,111 patients













d infection (HAI) and no-HAI groups for different admissions (which
not be linked to the Scottish Morbidity Record (SMR) dataset, 10
tish residents), 7 patients had no SMR01 record (still in hospital or
an SMR01 record for the admission during which they had an HAI
admission contained more than one HAI, the state-change to HAI
n the HAI state until death/discharge/censored.
Table I
Baseline descriptive unadjusted characteristics of patients during their admission (63,014 non-HAI and 877 HAI admissions)
Characteristic Category HAI Non-HAI All Median post-infection LOS for
HAI admission (IQR)
Median total LOS
for HAI admission (IQR)
Median LOS for non-HAI
admission (IQR)(N ¼ 877) (N ¼ 63,014) (N ¼ 48,104)
Age (years) <40 48 (5.5) 9203 (14.6) 9251 (14.5) 12.5 (6e25.25) 26 (10e46.5) 2 (1e3)
40e49 62 (7.1) 6041 (9.6) 6103 (9.6) 14 (7e27.5) 23.5 (14e46.25) 2 (1e5)
50e59 134 (15.3) 9502 (15.1) 9636 (15.1) 12 (6e28.75) 23 (11.25e49.25) 3 (1e6)
60e69 157 (17.9) 11,388 (18.1) 11,545 (18.1) 13 (5e31) 26 (13e47) 3 (2e7)
70e79 221 (25.2) 13,232 (21) 13,453 (21.1) 16 (6e38) 30 (14e56) 4 (2e9)
80 255 (29.1) 13,648 (21.7) 13,903 (21.8) 17 (8e40) 37 (20e67.5) 6 (2e16)
Sex Male 437 (49.8) 29,711 (47.1) 30,148 (47.2) 15 (7e37) 30 (15e55) 3 (1e7)




[0] No stay e not known 227 (25.9) 22,506 (35.7) 22,733 (35.6) 16 (6e36.5) 30 (15e57.5) 3 (1e6)
[0] No score 272 (31) 21,080 (33.5) 21,352 (33.4) 17 (7e38) 31.5 (16e64.25) 3 (1e7)
[1e2] Mild 230 (26.2) 13,011 (20.6) 13,241 (20.7) 14 (6e32.5) 29 (13e51.75) 4 (2e10)
[3e5] Moderate 117 (13.3) 4658 (7.4) 4775 (7.5) 12 (6e30) 27 (14e55) 5 (2e12)




1 (most deprived) 170 (19.4) 12,534 (19.9) 12,704 (19.9) 13.5 (5.25e31.5) 29 (13.25e55.5) 3 (1e8)
2 267 (30.4) 16,556 (26.3) 16,823 (26.3) 18 (6e40) 31 (14e62) 3 (1e8)
3 158 (18) 11,934 (18.9) 12,092 (18.9) 14.5 (7.25e33.75) 26.5 (15e50.75) 3 (1e8)
4 121 (13.8) 10,215 (16.2) 10,336 (16.2) 12 (7e26) 30 (15e48) 3 (1e7.5)
5 (least deprived) 158) (18) 11,438 (18.2) 11,596 (18.1) 16 (7.25e38.75) 29.5 (17e60.75) 3 (1e8)
Unknown 3 (0.3) 337 (0.5) 340 (0.5) 19 (13e31.5) 39 (29.5e46.5) 2 (1e5)
Emergency
admission
No 123 (14) 14,026 (22.3) 14,149 (22.1) 11 (5e23) 20 (10.5e35.5) 2 (1e5)
Yes 754 (86) 48,988 (77.7) 49,742 (77.9) 16 (7e37) 31 (15e58) 4 (2e9)
Specialty group Medicine 434 (49.5) 35,589 (56.5) 36,023 (56.4) 16 (7e36) 33 (18e59.75) 3 (1e8)
High dependence 38 (4.3) 1034 (1.6) 1072 (1.7) 23.5 (13e37.75) 34.5 (20.25e58.75) 6 (3e12)
Intensive care 65 (7.4) 2170 (3.4) 2235 (3.5) 17 (7e39) 31 (15e47) 4 (2e9)
Obstetrics and gynaecology 10 (1.1) 1793 (2.8) 1803 (2.8) 8.5 (3.5e17.5) 15.5 (8.25e23.25) 1 (1e3)
Surgery 330 (37.6) 22,255 (35.3) 22,585 (35.3) 13 (6e31) 23 (11e47) 3 (1e7)
Other 0 173 (0.3) 173 (0.3) 1 (1e4)
Overall 15 (6e35) 30 (14e56) 3 (1e8)
HAI, healthcare-associated infection; LOS, length of stay; IQR, interquartile range.
Charlson Comorbidity Index score was calculated based on comorbidities recorded during previous admissions to hospital. Patients with no stay within the previous two years are classed as not


































Excess LOS calculated using admission level model (in days) due to HAI shown for HAI groups
HAI typea HAI admissions Non-HAI admissions Excess LOS (days) SDb 95% CI
All HAI 877 63,014 7.8 1.1 5.7e9.9
Bloodstream infectionc 158 63,733 11.4 2.8 5.8e17.0
Gastrointestinal infection 139 63,752 6.0 3.4 e0.7 to 12.7
Lower respiratory infection 155 63,736 7.3 2.8 1.8e12.7
Pneumonia 81 63,810 16.3 4.5 7.5e25.2
Surgical site infection 130 63,761 9.8 2.7 4.5e15.0
Urinary tract infection 188 63,703 e1.0 1.7 e4.3 to 2.3
Otherd 26 63,865 14.0 9.1 e3.9 to 31.8
LOS, length of stay; HAI, healthcare-associated infection; SD, standard deviation; CI, confidence interval.
N ¼ 877 HAI admissions in total as this analysis was based on admissions which could be linked.
a For patients with multiple HAI admission is reported in the infection type of the first infection.
b Based on 50 Bootstrap (95% CI for excess LOS was calculated based on the fact that the access LOS follow a normal distribution).
c Included catheter-related infection type 3 (catheter-related bloodstream infection with microbiological documentation of the relationship
between the vascular catheter and the BSI).
d Small numbers of infections, including skin soft tissue; bone and joint; cardiovascular; eye, ear, nose and throat; and systemic infections. These
infections made up 3% of the total HAI but within this group there was a wide range of organs affected by this diverse group of HAIs.
Table III
Rank order of frequency of infection compared to excess LOS within the incidence cohort
Rank Incidence rate per 100,000 AOBD Excess LOS per infection Total annual estimated AOBD
HAI type Incidence rate per 100,000 AOBD HAI type Excess LOS per infection (days) HAI type Total annual estimated AOBD
All HAI 249.6 All HAI 7.8 All HAI 58,010
1 UTI 51.2 PN 16.3 BSI 15,830
2 BSI 44.7 Other 14.0 PN 10,270
3 LRI 44.2 BSI 11.4 SSI 10,030
4 GI 39.2 SSI 9.8 LRI 7600
5 SSI 35.3 LRI 7.3 GI 7540
6 PN 23.5 GI 6.0 Other 6650
7 Other 13.6 UTI 0 UTI 0
LOS, length of stay; AOBD, acute occupied bed-days; HAI, healthcare-associated infection; UTI, urinary tract infection; BSI, bloodstream infection;
LRI, lower respiratory tract infection; GI, gastrointestinal infection; SSI, surgical site infection; PN, pneumonia.
Total HAI admissions: 877 (which were linked to LOS data). Incidence data are reported elsewhere [30].
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 23e31 27deemed to be followed, allowing estimation of asymptotic 95%
confidence intervals using the standard error calculated
derived from the 50 bootstrap samples.
The multi-state modelling was performed using the etm
package in R (version 3.5.1) [29].
Ethics
This study was surveillance and therefore was confirmed as
ineligible for ethical review (Bailey A. Personal communication
to S. Stewart, September 8th, 2016. South East Scotland
Research Ethics Service). It was approved by national infor-
mation governance approvals: Public Benefit of Health and
Social Care: Incidence study: 1617-0037.Results
In total, 877 HAI-related admissions and 63,014 non-HAI-
related admissions were included within the analysis
(Figure 1). Admissions were excluded from the analysis if the
patient did not have a valid Community Heath Index number
(CHI) (N ¼ 17), or were diagnosed with HAI on the last day of
their stay or on the day they died (N ¼ 11). Patients were
censored after 180 days’ post admission and censored if theywere discharged to another hospital, since this reduced the
influence of outliers. Consequently, two admissions with HAI
were treated as non-HAI admissions due to the HAI occurring
more than 180 days after initial admission.
Within the included adult admissions, the median patient
age at admission was 66 years (interquartile range: 51e78);
52.8% were female. HAIs were identified a median of 9 days
[4e19] after admission to hospital. The median LOS for
admissions with HAI was 30 days [14e56] and for admissions
with no HAI was 3 days [1e8]. At the end of the study, 649 (74%)
HAI-related admissions had been discharged from hospital, 149
(17.0%) had died in hospital, and 79 (9.0%) remained in hospi-
tal. By contrast, 58,208 (92.4%) non-HAI-related admissions
were discharged from hospital, 2414 (3.8%) died in hospital and
2392 (3.8%) remained in hospital.
The excess LOS for all HAI types was 7.8 days (95% CI:
5.7e9.9). The rank order of highest to lowest impact was
pneumonia (16.3 days; 7.5e25.5), combined other HAI types
(14 days;e3.9 to 31.8), BSI (11.4 days; 5.8e17.0), SSI (9.8 days;
4.5e15.0), LRI (7.3 days; 1.8e12.7), GI (6 days; e0.7 to 12.7),
and UTI showing no excess LOS (Table II). Combined ‘other’
comprise a small number of infections, including SST, BJ, CV,
EENT, and systemic infections. These infections made up 26
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 23e3128(3%) of the total HAI but within this group a wide range of
organs are affected by this diverse HAI group.
The incidences of infection types with the greatest excess
LOS were low: pneumonia 23.5 per 100,000 acute occupied
bed-days (AOBD); other infections 13.6 per 100,000 AOBD [30]
(Table III). BSI ranked second highest incidence at 44.7 per
100,000 AOBD; when the total annual number of excess bed-
days was calculated using estimated total annual number of
HAIs within Scotland, BSI had the greatest impact on acute
care, with pneumonia second and SSI third [30] (Table III).Discussion
This hospital incidence study is the first in the UK for more
than 20 years to analyse LOS attributed to HAI derived from all
adult specialties. It addresses the risk of time-dependent bias
using a multi-state modelling approach and has found that the
excess LOS attributable to HAI was 7.8 days (95% CI: 5.7e9.9)
(Table II). Studies that account for time-dependent bias are rare
in the published literature, and studies continue to be published
without taking account of time-dependent bias [31e34].
Themedian LOS for HAI patients was 30 days and for non-HAI
patients was 3 days (Table I). Patients within this study with HAI
stayed in hospital for a substantially longer time than patients
without HAI, and acquired an infection a median of 9 days (IQR:
4e19) into their stay [30]. This difference reflects the age,
comorbidities, and severity of illness of patients who develop
HAI, since many of these patients will stay in hospital for an
extended period even if they do not develop HAI [30,35].
Studies continue to report the difference in total LOS between
patients with and without HAI and attribute this difference
wholly to HAI [31e33,36e48]. Patients with complex conditions
and multiple morbidities are often at greater risk of developing
HAI due to their intrinsic risk factors, or are exposed to
extrinsic risks as a result of the treatment they receive during
their hospital stay; these patients also potentially require a
longer duration of treatment within hospital, increasing their
risk of developing HAI. Using a simple comparison of duration of
hospital admissions for HAI cases and non-cases would over-
estimate the excess LOS by 3.5 times (27 days compared with
the estimate from the multi-state modelling of 7.8 days excess
LOS). A systematic review identified seven studies that com-
pared time-fixed comparisons methods to multi-state models
resulting in estimates of the LOS to HAIs that were, on average,
9.4 days longer or 2.4 times greater than those generated using
multi-state models [49]. These seven studies were undertaken
in different countries and included studies that reported a
range of infection types and causative organisms. Other studies
have found this difference to be as high as 5.6 times [50].
This study’s finding of 7.8 days excess LOS attributable to
HAI is consistent with the estimates available from those few
studies which have assessed the excess LOS attributable to HAI
within a whole-hospital setting [50e53]. Preventing one case of
HAI will reduce the average stay by 7.8 days. However, patients
who are at risk of HAI will still be present in the hospital over a
longer period due to their underlying health and will remain
vulnerable to HAI throughout their stay. A total of 58,000 bed-
days are occupied due to HAI in Scotland annually, which is
equivalent to a small general hospital accommodating only
patients with HAI [54]. The average LOS in NHS Scotland in
2018/19 was 6.0 days overall; 3.4 days for elective admissions,6.6 for emergency admissions, and 13.2 for transfers [55]. For
each HAI prevented, at least one other patient could have been
treated, or two elective admissions could have been removed
from a waiting list. Thus, even a reduction of 10% in HAI inci-
dence has the potential to free up 5800 bed-days that could be
used to treat an average of 1706 elective patients in Scotland
annually and help to reduce the number of patients awaiting
planned treatments [56e58].
Although UTIs showed no excess LOS overall in the ECONI
study, this is not to say that the HAI had no impact on the
patients or the health system e they simply did not cause
patients to stay longer in hospital. The impact of UTIs on the
healthcare system has been demonstrated elsewhere [59,60].
Further, UTIs are associated with secondary BSI, and therefore
the importance of prevention of UTI remains critical. Three
studies reported excess LOS due to UTI caused by any organism
using a multi-state modelling approach and their estimates of
excess LOS range from 0.34 to 5.3 days [50,51,61]. However,
these studies were undertaken in China (lowest value), Aus-
tralia, and Germany (higher value), with no comparable studies
identified from the UK.
The three HAI types having the greatest impact on LOS per
infection were pneumonia, BSI, and SSI (Table II). BSI not only
had the second greatest impact on LOS but patients being
treated for BSI accounted for the greatest number of bed-days
when incidence was extrapolated at a national level (Table III).
BSI, pneumonia, and SSI are high-volume and high-impact
infections, and a focus on reducing these HAI types should be
prioritized. To date in the UK and internationally, much of the
focus has been on catheter-related BSI and ventilator-
associated pneumonia [62,63]. However, the impact of these
infections on LOS is such that a more comprehensive look at
wider IPC interventions for non-device-associated BSI and
pneumonia and beyond ICU is required.
All-cause mortality was higher within the HAI group (17.0%)
compared to that in the non-HAI group (3.8%). A greater pro-
portion of patients who developed HAI remained in hospital
(9.0%) compared with non-HAI cases (3.8%). When the effect of
a prognosis of death within six months for an underlying con-
dition is considered, the impact of HAI on mortality is modified
[64,65]. These deaths cannot be attributed to the HAI and
these observations show how important it is to consider the
complexity of attribution of mortality to HAI.
There are several limitations to this study. Regarding record
linkage from national datasets, some patients were excludede
for example, patients who did not have valid CHI number, who
remained in hospital, or who had not been discharged,
although this number was small (N ¼ 33) (Figure 1). Whereas
multi-state modelling is proposed as the best methodology for
estimating excess LOS due to HAI, this analysis did not account
for patient characteristics such as severity of illness and
comorbidities [6,10,14,66]. Although it is possible to include
adjustments for all patient characteristics using pseudo-
observations, the interpretation becomes complex, in that
the adjusted excess LOS estimate was taken from the model
intercept, and could therefore be interpreted as the excess
LOS caused by infection in the patients who are in the refer-
ence group (aged <30 years, male, no prior hospital stay, most
deprived area, elective, admission, treated in a medical spe-
cialty). This ‘reference’ group of patients does not reflect the
majority of patient admissions and therefore could potentially
overestimate the attributable LOS for the majority of patients.
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 23e31 29Another benefit of the multi-state modelling approach is that
cases and controls are not lost due to issues with matching,
which often lead to bias as certain groups of cases are more
likely to be excluded due to difficulties in finding controls (e.g.
those with rare admission diagnosis, or young patients, or those
in relatively small hospitals).
These results would be generalizable to UK NHS hospital
settings as hospital care pathways; laboratory testing and
treatments are broadly similar throughout the NHS in the UK.
How far these findings are generalizable is unknown. The
estimates of excess LOS are very similar to those reported
overall within high-income countries, although differences in
healthcare systems, case mix and incidence of different HAIs
will affect overall outcome estimates.
In conclusion, this was a comprehensive study of incidence
surveillance across whole-hospital populations and all types of
HAI using ECDC case definitions of HAI and record linkage [17].
Excess LOS is the most important factor when considering the
impact of HAI on patient services. Whereas a reduction in HAI
incidence frees up hospital bed-days, allowing additional
patients to be treated, the number of bed-days made available
is less than previously estimated. However, the at-risk patients
would still be treated in hospital for an extended period. These
results can be used to inform studies assessing the cost-
effectiveness of interventions to prevent HAI.
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